Detalles de la búsqueda
1.
Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy.
J Infect Dis
; 222(3): 381-390, 2020 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31714954
2.
Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda.
Front Immunol
; 14: 1113194, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36999017
3.
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences.
Hum Vaccin Immunother
; 19(2): 2240690, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37553178
4.
Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy.
Front Immunol
; 14: 1183983, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37205095
5.
Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens.
Front Immunol
; 14: 1148877, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37153598
6.
Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) - a protocol for two parallel, open-label, randomised controlled trials.
Trials
; 24(1): 465, 2023 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37480110
7.
Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial.
PLoS One
; 17(11): e0275927, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36327320
Resultados
1 -
7
de 7
1
Próxima >
>>